The Bethesda System for Reporting Thyroid Cytopathology
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2009/11/01
-
Journal
-
Indian UGC (journal)
-
Refrences30
-
Citations897
-
Edmund S. Cibas Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
-
Syed Z. Ali Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Cite
Cibas, Edmund S., and Syed Z. Ali. “The Bethesda System for Reporting Thyroid Cytopathology”. Thyroid, vol. 19, no. 11, 2009, pp. 1159-65, https://doi.org/10.1089/thy.2009.0274.
Cibas, E. S., & Ali, S. Z. (2009). The Bethesda System for Reporting Thyroid Cytopathology. Thyroid, 19(11), 1159-1165. https://doi.org/10.1089/thy.2009.0274
Cibas ES, Ali SZ. The Bethesda System for Reporting Thyroid Cytopathology. Thyroid. 2009;19(11):1159-65.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the endocrine glands
Clinical endocrinology
Medicine
Internal medicine
Specialties of internal medicine
Nutritional diseases
Deficiency diseases
Science
Biology (General)
Science
Chemistry
Organic chemistry
Biochemistry
You May Also Like
- Bisphenol A: An endocrine and metabolic disruptor
- Human ovarian follicular development: From activation of resting follicles to preovulatory maturation
- Management of clinically non-functioning pituitary adenoma
- Epidemiology of Type 1 Diabetes
- The metabolic syndrome: prevalence in worldwide populations
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| 10.5858/2001-125-0484-AOFNAO | 2001 | |||
| 10.1016/S0272-2712(18)30434-7 | Clinics in Laboratory Medicine |
| 1993 | |
| 10.1016/S0272-2712(18)30434-7 | Oncology |
| 1999 | |
| 10.1016/S0272-2712(18)30434-7 | 1994 | |||
| 10.1016/S0272-2712(18)30434-7 | 1993 |
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
Risks of malignancy in the major nongynecologic cytopathology reporting systems: Critiques and discussions | Cancer Cytopathology |
| 2024 | |
Diagnostic models for predicting malignancy in thyroid nodules classified as Bethesda Category III in an endemic region | Diagnostic Cytopathology |
| 1 | 2024 |
| Comments on “Diagnostic models for predicting malignancy in thyroid nodules classified as Bethesda category III in an endemic region” | Diagnostic Cytopathology |
| 2024 | |
| Assessment of the risk of malignancy in Bethesda III thyroid nodules: a comprehensive review | Endocrine |
| 2024 | |
A Comprehensive Approach to the Thyroid Bethesda Category III (AUS) in the Transition Zone Between 2nd Edition and 3rd Edition of The Bethesda System for Reporting Thyroid Cytopathology: Subcategorization, Nuclear Scoring, and More | Endocrine Pathology |
| 2024 |
Citations Analysis
The category
Medicine: Medicine (General) 503
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Cytokine Genes <i>TNF</i>, <i>IL1A</i>, <i>IL1B</i>, <i>IL6</i>, <i>IL1RN</i> and <i>IL10</i>, and Childhood-Onset Mood Disorders and was published in 2008. The most recent citation comes from a 2024 study titled The Effect of Rapid Onsite Evaluation on the Satisfaction of Ultrasound-Guided Thyroid Fine Needle Aspiration: A Meta-Analysis. This article reached its peak citation in 2017, with 101 citations. It has been cited in 278 different journals, 21% of which are open access. Among related journals, the Thyroid cited this research the most, with 59 citations. The chart below illustrates the annual citation trends for this article.